It means the effect, if present, is too small or inconsistent to reliably treat a diagnosed circulatory condition like claudication or peripheral artery disease on its own
Two RCTs are in progress : NCT01528540 is testing the micronutrient cocktail plus pregabalin ( a presynaptic voltage-gated blocker of the calcium channel) or placebo in all-comers
They verify your semaglutide medication coverage and submit the prior authorization request directly to your insurance provider, saving you time and confusion in navigating the system independently
Additionally, we performed quantitative amino acid profiling of individuals from konzo-prone regions which suggests a deficiency in cystine, the precursor for the antioxidant glutathione, which is required by GPx3 to effectively remove ROS from circulation 22
While the peptide appeared well tolerated in these trials, the absence of reproducible clinical benefit meant the molecule did not progress to approval or further late-stage studies
Pochini et al., 2004